123618-00-8 Usage
Description
Fedotozine is a pharmaceutical compound that functions as a kappa (κ) opioid receptor agonist. It is characterized by its ability to selectively target and activate the kappa opioid receptors, which are involved in the modulation of pain perception and gastrointestinal motility.
Uses
Used in Pharmaceutical Industry:
Fedotozine is used as a therapeutic agent for the treatment of irritable bowel syndromes (IBS). Its action as a kappa opioid receptor agonist helps in alleviating the symptoms associated with IBS, such as abdominal pain, discomfort, and altered bowel habits. fedotozine's selective targeting of kappa receptors allows for a more focused approach to managing IBS, potentially reducing side effects commonly associated with broader opioid receptor agonists.
Additionally, fedotozine is recognized for its potential as a visceral analgesic. This application is based on its ability to modulate pain perception in the gastrointestinal tract, providing relief from pain and discomfort associated with various gastrointestinal disorders. The selective activation of kappa opioid receptors by fedotozine may offer a more targeted and effective approach to managing visceral pain, with fewer side effects compared to traditional analgesics.
Check Digit Verification of cas no
The CAS Registry Mumber 123618-00-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,6,1 and 8 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 123618-00:
(8*1)+(7*2)+(6*3)+(5*6)+(4*1)+(3*8)+(2*0)+(1*0)=98
98 % 10 = 8
So 123618-00-8 is a valid CAS Registry Number.
InChI:InChI=1/C22H31NO4/c1-7-22(23(2)3,18-11-9-8-10-12-18)16-27-15-17-13-19(24-4)21(26-6)20(14-17)25-5/h8-14H,7,15-16H2,1-6H3/t22-/m0/s1
123618-00-8Relevant articles and documents
(+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
-
, (2008/06/13)
(+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine of formula STR1 is a medicament of use in gastroenterology.